Results 6,721-6,740 of 14,090 for speaker:Marc MacSharry
- Public Accounts Committee: IDA - Financial Statement 2016 (5 Oct 2017)
Marc MacSharry: The owner was a third party in the private sector.
- Public Accounts Committee: IDA - Financial Statement 2016 (5 Oct 2017)
Marc MacSharry: That is fine. In some quarters projected population growth for Dublin has been put at 700,000 by 2025. On the basis of the lack of optimum levels of commercial office space and, obviously, housing, and given that Mr. Shanahan said talent is ultimately the deciding factor for FDI decision makers, what strategy and resources has the IDA employed to diversify the priority? Mr. Shanahan can...
- Public Accounts Committee: IDA - Financial Statement 2016 (5 Oct 2017)
Marc MacSharry: It is a problem unless someone is going to live in and commute from Carrick-on-Shannon.
- Public Accounts Committee: IDA - Financial Statement 2016 (5 Oct 2017)
Marc MacSharry: Following from that, what percentage of €95 million in grant aid went to regions outside Dublin or the east coast?
- Public Accounts Committee: IDA - Financial Statement 2016 (5 Oct 2017)
Marc MacSharry: The east coast.
- Public Accounts Committee: IDA - Financial Statement 2016 (5 Oct 2017)
Marc MacSharry: Okay.
- Written Answers — Department of Public Expenditure and Reform: Garda Stations (10 Oct 2017)
Marc MacSharry: 88. To ask the Minister for Public Expenditure and Reform the location of the site for the new Garda headquarters (details supplied) in County Sligo; if it has been procured; the status of the project; the timeframe for planning, construction and completion; and if he will make a statement on the matter. [42318/17]
- Written Answers — Department of Education and Skills: School Accommodation (10 Oct 2017)
Marc MacSharry: 177. To ask the Minister for Education and Skills the status of the allocation for the provision of a multi purpose room which is needed for the pupils and staff of a school (details supplied); if approval will be given; the timeframe involved; and if he will make a statement on the matter. [42324/17]
- Written Answers — Department of Justice and Equality: Alcohol Sales Legislation (10 Oct 2017)
Marc MacSharry: 216. To ask the Tánaiste and Minister for Justice and Equality further to recent legislation passed which provides for craft brewers licenced to sell their products to brewery visitors between certain times, if the licence is a saleable asset; if it is transferable; if they can be converted to full licences in time; if the licence will expire if a business closes down; the way in which...
- Written Answers — Department of Health: Medicinal Products Reimbursement (10 Oct 2017)
Marc MacSharry: 436. To ask the Minister for Health if a High Court appeal as set out under section 27 of the Health (Pricing and Supply of Medical Goods) Act 2013 is the only mechanism for a pharmaceutical company to seek reimbursement of a medicine in circumstances in which the HSE has decided not to reimburse the medicine; and if he will make a statement on the matter. [42313/17]
- Written Answers — Department of Health: Medicinal Products Reimbursement (10 Oct 2017)
Marc MacSharry: 437. To ask the Minister for Health his plans to establish an independent review mechanism to review appeals by pharmaceutical companies in circumstances in which the HSE has decided not to reimburse their medicinal products; and if he will make a statement on the matter. [42314/17]
- Written Answers — Department of Health: Medicinal Products Reimbursement (10 Oct 2017)
Marc MacSharry: 438. To ask the Minister for Health the difference in approach taken by Irish and other European assessors of a medicine's clinical and cost effectiveness with regard to treatments for rare disease in circumstances in which certain medicines are readily available in over 22 other European countries but have been refused access here; and if he will make a statement on the matter. [42315/17]
- Written Answers — Department of Health: Medicinal Products Reimbursement (10 Oct 2017)
Marc MacSharry: 439. To ask the Minister for Health the role the US Food and Drug Administration has in assessing a medicine for reimbursement here under the Health (Pricing and Supply of Medical Goods) Act 2013; if a conflicting position between the FDA and the European Medicines Authority has a material role in assessing such medicines; and if he will make a statement on the matter. [42316/17]
- Public Accounts Committee: Business of Committee (12 Oct 2017)
Marc MacSharry: Transport Infrastructure Ireland, TII, is waiting at the door and there are still some bits of correspondence to get through that I, for one, certainly have a view on.
- Public Accounts Committee: Business of Committee (12 Oct 2017)
Marc MacSharry: Exactly and they make take some time to get through.
- Public Accounts Committee: Business of Committee (12 Oct 2017)
Marc MacSharry: That is the Chairman's view. There are at least two of major importance to me.
- Public Accounts Committee: Business of Committee (12 Oct 2017)
Marc MacSharry: Can we deal with TII and then return to correspondence in a more detailed manner?
- Public Accounts Committee: Business of Committee (12 Oct 2017)
Marc MacSharry: That is a problem then because I am lead speaker and I have to go on RTÉ at 11 o'clock.
- Public Accounts Committee: Business of Committee (12 Oct 2017)
Marc MacSharry: We just spent half an hour on one item of correspondence.
- Public Accounts Committee: Business of Committee (12 Oct 2017)
Marc MacSharry: I am only asking.